A rapid bioassay for measuring inhibin activity by Ramasharma, K. et al.
BIOLOGY OF REPRODUCTION 20, 831-835 (1979)
831
A Rapid Bioassay for Measuring Inhibin Activity
K. RAMASHARMA, H. M. SHASHIDARA MURTI-IY and N. R. MOUDGAL
Laboratory of Endocrine Biochemistry,
Department of Biochemistry,
Indian Institute of Science,
Bangalore 560 012, India
ABSTRACT
A sensitive and rapid bioassay of inhibin is described. Swiss albino female mice, 27 days old,
weighing 25-30 g, were primed with 20 IU hCG, given in 2 equal doses, administered at 0900 h
and 1800 h. An increment of 200% in uterine weight could be observed when the animals were
autopsied the next day at 1000 h. The validity of the endpoint chosen, as a function dependent on
FSH, was shown by the fact that neutralization of endogenous FSH by FSH antiserum led to an
inhibition of uterine weight increase. Further injection of the inhibin material caused an actual
reduction in the heightened levels of FSH (ng/ml) brought about by hCG: Control, 207 ± 13.6;
hCG, 365 ± 28.8 and hCG + inhibin, below the detection level of radioimmunoassay.
Inhibin preparation from ovine testicular extract when tested at 3 dose levels showed a dose
dependent and significant suppression in uterine weight increase. The assay was statistically valid
#{128}= 2.5; slope 23.9; A = 0.104 and intra- and interassay variation = 8.3% and 11.7%, respectively.
Since the mouse uterine weight assay is specific, has greater sensitivity and is uniformly repro-
ducible, it is suggested that this assay procedure is ideally suited to assess the activity of different
inhibin test preparations as well as to follow the purification of inhibin activity from crude mate-
rial.
INTRODUCTION
Assaying the biological activity of inhibin-
like material has posed problems for the inves-
tigators in this area for quite some time. Some
of the assays proposed though specific and
sensitive have been found to be cumbersome
and time consuming for routine usage (Baker
et al., 1976; Nandini et al., 1976; and Eddie et
al., 1977).
Recently, Chari et al. (1976) reported an
assay procedure which is dependent on the
ability of inhibin preparations to suppress the
ovarian weight increase seen in immature rats
given 50 IU hCG. Being essentially a 24 h assay,
this procedure has proved attractive. The
investigators, however, while describing the
method have not provided adequate reasons for
assuming that the reduction in ovarian weight
seen is due to suppression in FSH levels conse-
quent to inhibin administration.
The assay procedure we report here em-
ploys an essentially similar model system, but
uses the immature mouse as the experimental
animal and the inhibition of uterine weight
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increment as an index of inhibin activity. This
procedure is very specific as well as more
sensitive compared to the rat ovarian weight
method. The validity of using this endpoint for
assaying inhibin activity has also been adequate-
ly substantiated.
MATERIALS AND METHODS
General Methodology
Swiss albino female mice, 27 days of age, weighing
25-30 g bred in the Central Animal Facility of this
Institute were used. The animals were housed under a
light:dark schedule of 14 h:10 h with pelleted feed
(Hindustan Lever, Bombay) and water provided ad
libitum. Wistar strain of rats 27 days of age, weighing
approximately 40 g, bred in this Institute, were also
used.
A highly purified preparation of hCG (gift of Dr.
Canfield) was used for priming the animals. The
antiserum to ovine FSH used was raised in monkeys
and characterized for specificity according to methods
described earlier (Sheela Rani and Moudgal, 1977).
FSH in the mouse serum was assayed using the
NIAMDD rat FSH radioimmunoassay (RIA) kit. The
validity of using this assay system for measuring mouse
serum FSH has been established by Murr et al. (1973).
Preparation of Ovine
Testicular Inhibin Material
The method used to obtain a crude extract was
similar to that described by us earlier (Nandini et al.,
1976). Some of the fractions used for testing the
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increase in uterine weight. In the first experi-
ment, simultaneous injection of FSH antiserum
and hCG at 2 different s.c. sites led to an
inhibition in uterine weight increase, suggesting
that for expression of hCG activity, endogenous
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activity were obtained after further processing of the
crude extract. The details of fractionation have been
described elsewhere (Shashidhara Murthy et al., 1979).
The preparations tested were crude ammonium sul-
phate fraction (P1), a fraction obtained after chroma-
tography on Sephadex G-75 column (P2) and that ob-
tained by negative absorption on DEAE cellulose (P3).
Assay Protocol
The test material, dissolved in 0.2% gelatin, was
injected s.c. in 2 equal doses to 27-day-old, immature
mice or rats at 0800 h and 1700 Ii. The hCG also
dissolved in 0.2% gelatin was administered s.c. in 2
equal doses at 0900 h and 1800 h of the same day.
The animals were autopsied at 1000 h of the next day
and the ovaries or the uteri removed, trimmed free of
fat and weighed on a torsion balance to the nearest 0.2
mg. Each mouse received a total dose of 20 IV hCG
while the dose per rat was 60 IU.
Statistical Analysis
The results were analyzed for sensitivity, precision,
parallelism and intra- and interassay variation accord-
ing to the standard procedures of Cornfield (1970)
and Finney (1964).
RESULTS
Response to hCG
as a Function of Dose
and Age of the Animal
Prior to testing the ability of inhibin to
block the response to hCG and to standardize
the age of the mice as well as the dose of hCG
to be used, the following 2 pilot studies not
involving the use of inhibin were undertaken. In
the first study a group of mice of different
ages ranging from 22-29 days were injected s.c.
with 20 IU of hCG in 2 equal doses and the
uterine weight increment 24 h after the first
injection was recorded. Compared to the
vehicle controls, hCG treatment resulted in
significant increment when mice of 27 and 29
days of age were used (Fig. 1). Since Day 30
coincides with the day of vaginal opening, mice
27 days of age were used in all subsequent
studies to avoid confusion and ambiguity. It is
evident from Fig. 2 that the increment in
uterine weight is directly proportional to the
dose of hCG administered, 20 IU of hCG
providing optimal response.
Validity of Using the
Inhibition in Uterine Weight
Increase as an Endpoint of
Inhi bin Activity
Two experiments were designed to ascertain
the mechanism by which hCG induces an
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FIG. 1. Age dependent response to hCG. Immature
mice 22-29 days of age were primed with 20 IV hCG
given in 2 equal doses. The animals were autopsied
16 h after the last injection of hCG and uterine
weights (mg mean ± SD) determined. (See text for
further details.)
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FIG. 2. Dose dependent response to hCG using
mouse uterine weight (mg mean ± SD) as an endpoint.
Immature 27-day-old mice were used. The animals
were autopsied 16 h after the last injection of hCG
which was administered in 2 equal doses. (See text for
further details.)
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TABLE 1. Ability of inhibin to suppress the increment
in FSH levels brought about by hCG.
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FSH is needed (Fig. 3). The FSH antiserum
used has been shown earlier by Jagannadha Rao
and Moudgal (1970) to neutralize mouse FSH,
but not to cross react with hCG.
In the second experiment, measurement of
FSH at stipulated time intervals after hCG
injection showed that within 1 h there was a
significant increment in endogenous FSH level
(Fig. 4). Injection of inhibin preparation 1 h
prior to injection of hCG resulted in abolition
of this increase (Table 1).
Use of the Mouse Assay to
Estimate the Relative Activity
of 3 Inhibin Preparations
The credibility of the assay for estimating
rapidly the relative activity of different frac-
tions obtained during purification of inhibin
was tested by determining the activity of 3
preparations P1, P2 and P3. It is evident from
Fig. 5 that these preparations can bring about
suppression of uterine weight increase in a dose
dependent manner. With increased purification,
the amount of material needed to bring about
significant suppression is also reduced. The
activity contained in as little as 50 g of the
FIG. 3. Effect of antiserum to o-FSH injected 1 h
prior to hCG injection on uterine weight (mg mean ±
SD) increase in mice. Antiserum dose shown here is
the total dose administered in 2 equal doses, 1 at 0800
h and the other at 1700 h. The remainder of the
experimental protocol is the same as in Fig. 2.
FIG. 4. Effect of hCG injection on serum FSH
levels. The hCG was administered at Oh and serum
samples collected at different time intervals thereafter.
The FSH (ng/ml; mean ± SD) in the serum was assayed
using the rat FSH RIA kit (NIAMDD, Bethesda MD)
(See text for further details.)
purified preparation (P3) could be safely
estimated. Assuming that the unit of activity is
that amount needed to bring about 50% sup-
pression in uterine weight, the preparation P3,
per mg protein, has relatively 1400 x the
activity of the crude or 15 units/mg protein.
Statistical Evaluation
of the Assay
The validation of assay procedure has been
checked using various statistical parameters
(Table 2). The method is highly sensitive
and gives reproducible results.
Treatment FSH (ng/ml)a
Control 207 ± 13.6
hCG 365 ± 28.8
Inhibin (1 mg P2) + hCG N.D.b
aMean ± SD.
bNot detectable; below the sensitivity of the
radioimmunoassay using 100 iI of plasma. The sensi-
tivity of the assay is 10 ng/tube. See text for details.
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TABLE 2. Statistical evaluation of the validity of
mouse uterine weight assay.
aRefers to the most highly purified preparation
presently available to us.
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FIG. 5. Comparison of relative inhibin activity of 3
inhibin preparations (P1, P2 and P3). The results are
expressed in terms of per cent suppression of increase
in uterine weight.; 100 - [Uterine weight (hCG +
inhibin) - uterine weight (control)I #{247}lUterine weight
(hCG) - uterine weight (control)l X 100.
Comparison of Rat Ovarian Weight
Assay Method with Mouse Uterine
Weight Assay Method
Fig. 6 shows that the mouse uterine weight
assay method is much more sensitive than the
rat ovarian weight assay, each dose of prepa-
ration (doubling dose) administered to the mice
producing a response which is significantly
different from the other. In the rat ovarian
weight assay, the response becomes significant
only when the dose is quadrupled.
DISCUSSION
The foregoing describes a simple bioassay
procedure for estimating the activity of inhibin
preparations. That the parameter used to
assess inhibin activity, namely the suppression
in uterine weight of mice treated with hCG and
inhibin preparation, is a valid one has been
demonstrated by using two different criteria.
Parameter Value
Sensitivity 50 Mga
lntra-assay variation 8.3%
lnterassay variation 11.7%
Sigma 2.5
Slope 23.9
(G) Departure from parallelism 0.610
(A) Index of precision 0.104
(r) Regression coefficient 0.76
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FIG. 6. Comparison of mouse uterine weight assay
with the rat ovarian weight assay. Preparation P1 was
tested at 3 dose levels in both the models. Note that
the suppression in uterine weight was significantly
different when compared with each dose level. P
value for A:B, BC and CD was 0.001. The rat
ovanan weight assay was relatively less sensitive with
the P value for the different groups being E:F 0.001,
F:G 0.01, GI-I not significant and F:H 0.01. Numbers
within the columns indicate per cent suppression.
Injection of hCG appears to result in an acute
discharge of FSH which perhaps by stimulating
follicular maturation and synthesis of estrogen
causes an increment in uterine weight. The
abolition of the hCG effect by simultaneous
injection of FSH antiserum corroborates the
above conclusion. Finally, injection of test
inhibin material brings about abolition of the
increment in FSH levels at 1 h after hCG
injection which is reflected in a significant
suppression in uterine weight at 24 h. The
above provides the rationale for using suppres-
sion of uterine weight of mice treated with hCG
as an index of inhibition of FSH secretion.
The inhibition of uterine weight increase
observed is dose dependent with respect to the
test material and the effective dose needed
to bring about 50% suppression is significantly
reduced, as is to be expected, with the progres-
sive purification of the product. The dose
response curves obtained with different prepa-
rations are parallel to each other which proves
the validity of the assay (Table 2). The smallest
dose of a highly purified preparation capable of
giving significant suppression over the hCG
control was 50 g. We believe that this could be
lowered with further purification. The values
for precision of the assay, the intra- and inter-
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assay variation etc., provided in Table 2, clearly
show that all the indices obtained are within
the range acceptable for a valid bioassay.
The superiority of the mouse uterine weight
assay over the rat ovarian weight assay becomes
evident when one observes that the difference
between the dose levels (doubling dose) is
significantly higher in the former. Inhibin
preparations from three different laboratories
have been tested by this method. All of them
have shown a dose dependent response and it
has been possible to obtain a relative activity
index with reference to our preparation. This
method is recommended as a good reliable
procedure for following the purification of
material having FSH suppressing activity. Even
though the method is less sensitive when
compared to the tissue culture assay procedure
of Eddie et al. (1977), it is a fast, simple and
reliable procedure which is not at all cumber-
some. Finally, use of mice is much more
economical in terms of animal cost and amount
of hCG used.
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